American global pharmaceutical company headquartered in Princeton, New Jersey
American global pharmaceutical company headquartered in Princeton, New Jersey
Industry analysis highlights key strategic questions surrounding AstraZeneca and BMS, including focus areas in oncology, cardiology, patent-cliff avoidance, and U.S. market expansion.
Shares of AstraZeneca fell sharply following market speculation regarding a potential mega-merger. Industry reports linked the stock decline to unconfirmed rumors of a deal involving Bristol Myers Squibb.
Pharmaceutical giant AstraZeneca reportedly held talks with rival Bristol Myers Squibb concerning a potential merger valued at $400 billion, according to a source reported by Reuters.